scispace - formally typeset
A

Asmaa Tazi

Researcher at University of Paris

Publications -  42
Citations -  1695

Asmaa Tazi is an academic researcher from University of Paris. The author has contributed to research in topics: Streptococcus agalactiae & Medicine. The author has an hindex of 18, co-authored 36 publications receiving 1364 citations. Previous affiliations of Asmaa Tazi include French Institute of Health and Medical Research & Pasteur Institute.

Papers
More filters
Journal ArticleDOI

Multiplex PCR Assay for Rapid and Accurate Capsular Typing of Group B Streptococci

TL;DR: A simple, specific, and sensitive two-multiplex-PCR assay that enabled the detection of all known group B streptococcal capsular polysaccharides and well adapted for GBS capsularpolysaccharide typing in large-scale epidemiological studies.
Journal ArticleDOI

Rapid detection of the "highly virulent" group B Streptococcus ST-17 clone.

TL;DR: In conclusion, an ST-17-specific gbs2018 allele was identified and used to develop a sensitive and specific rapid-screening molecular assay for identifying ST- 17 "highly virulent" GBS.
Journal ArticleDOI

Invasive group B streptococcal infections in infants, France.

TL;DR: Clinical features and molecular characterization of 109 group B streptococci causing neonatal invasive infections were determined over an 18-month period in France, and the hypervirulent clone ST-17 was recovered in 80% of meningitis cases.
Journal ArticleDOI

Group B streptococcus neonatal invasive infections, France 2007–2012

TL;DR: LOD represents almost 60% of cases of neonatal GBS disease in France and other countries in which IAP has been implemented, reinforcing the need to develop new prevention strategies targeting CC17, which is predominant in GBS neonatal infections.